Literature DB >> 29613772

Decoding Surface Interaction of VIVO Metallodrug Candidates with Lysozyme.

Giuseppe Sciortino1,2, Daniele Sanna3, Valeria Ugone2, Agustí Lledós1, Jean-Didier Maréchal1, Eugenio Garribba2.   

Abstract

The interaction of metallodrugs with proteins influences their transport, uptake, and mechanism of action. In this study, we present an integrative approach based on spectroscopic (EPR) and computational (docking) tools to elucidate the noncovalent binding modes of various VIVO compounds with lysozyme, a prototypical model of protein receptor. Five VIVO-flavonoid drug candidates formed by quercetin (que), morin (mor), 7,8-dihydroxyflavone (7,8-dhf), chrysin (chr), and 5-hydroxyflavone (5-hf)-effective against several osteosarcoma cell lines-and two benchmark VIVO species of acetylacetone (acac) and catechol (cat) are evaluated. The results show a gradual variation of the EPR spectra at room temperature, which is associated with the strength of the interaction between the square pyramidal complexes [VOL2] and the surface residues of lysozyme. The qualitative strength of the interaction from EPR is [VO(que)2]2- ≈ [VO(mor)2] > [VO(7,8-dhf)2]2- > [VO(chr)2] ≈ [VO(5-hf)2] > [VO(acac)2] ≈ [VO(cat)2]2-. This observation is compared with protein- ligand docking calculations with GOLD software examining the GoldScore scoring function ( F), for which hydrogen bond and van der Waals contact terms have been optimized to account for the surface interaction. The best predicted binding modes display an energy trend in good agreement with the EPR spectroscopy. Computation indicates that the strength of the interaction can be predicted by the Fmax value and depends on the number of OH or CO groups of the ligands that can interact with different sites on the protein surface and, more particularly, with those in the vicinity of the active site of the enzyme. The interaction strength determines the type of signal revealed ( rigid limit, slow tumbling, or isotropic) in the EPR spectra. Spectroscopic and computational results also suggest that there are several sites with comparable binding energy, with the V complexes distributing among them in a bound state and in aqueous solution in an unbound state. This kind of study and analysis could be generalized to determine the noncovalent binding modes of a generic metal species with a generic protein.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29613772     DOI: 10.1021/acs.inorgchem.8b00134

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  7 in total

1.  Multiple and Variable Binding of Pharmacologically Active Bis(maltolato)oxidovanadium(IV) to Lysozyme.

Authors:  Giarita Ferraro; Maddalena Paolillo; Giuseppe Sciortino; Eugenio Garribba; Antonello Merlino
Journal:  Inorg Chem       Date:  2022-10-07       Impact factor: 5.436

2.  Biospeciation of Potential Vanadium Drugs of Acetylacetonate in the Presence of Proteins.

Authors:  Giuseppe Sciortino; Valeria Ugone; Daniele Sanna; Giuseppe Lubinu; Simone Ruggiu; Jean-Didier Maréchal; Eugenio Garribba
Journal:  Front Chem       Date:  2020-05-07       Impact factor: 5.221

3.  Rationalizing the Decavanadate(V) and Oxidovanadium(IV) Binding to G-Actin and the Competition with Decaniobate(V) and ATP.

Authors:  Giuseppe Sciortino; Manuel Aureliano; Eugenio Garribba
Journal:  Inorg Chem       Date:  2020-11-30       Impact factor: 5.165

4.  ESI-MS Study of the Interaction of Potential Oxidovanadium(IV) Drugs and Amavadin with Model Proteins.

Authors:  Valeria Ugone; Daniele Sanna; Giuseppe Sciortino; Debbie C Crans; Eugenio Garribba
Journal:  Inorg Chem       Date:  2020-06-25       Impact factor: 5.165

5.  Spectroscopic/Computational Characterization and the X-ray Structure of the Adduct of the VIVO-Picolinato Complex with RNase A.

Authors:  Giarita Ferraro; Nicola Demitri; Luigi Vitale; Giuseppe Sciortino; Daniele Sanna; Valeria Ugone; Eugenio Garribba; Antonello Merlino
Journal:  Inorg Chem       Date:  2021-11-30       Impact factor: 5.165

Review 6.  Overview of Research on Vanadium-Quercetin Complexes with a Historical Outline.

Authors:  Agnieszka Ścibior
Journal:  Antioxidants (Basel)       Date:  2022-04-17

7.  Vanadium complex: an appropriate candidate for killing hepatocellular carcinoma cancerous cells.

Authors:  Hamid Bakhshi Aliabad; Soudeh Khanamani Falahati-Pour; Hadis Ahmadirad; Maryam Mohamadi; Mohammad Reza Hajizadeh; Mehdi Mahmoodi
Journal:  Biometals       Date:  2018-09-25       Impact factor: 2.949

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.